MedCare's Proprietary Non-Drug and Non-Surgical Treatment Program
for Urinary Incontinence Expands to Denver
New Sites Planned for Stamford, Milwaukee, Miami and Chicago
LISLE, Ill., April 2 /PRNewswire/ -- MedCare Technologies, Inc. (Symbol: MCAR) today announced the opening of The
MedCare Program in Denver, Colorado, in conjunction with Dr. Reuven Rosen and Dr. Eugene Heller at the Denver Urology
Clinic. This new site is the fourth unit in a series of nationally planned centers for the treatment of urinary incontinence using The
MedCare Program, a proprietary non-drug and non-surgical treatment protocol developed by MedCare Technologies. "Many
of my patients that would have had surgery are now successfully being treated using MedCare's non-invasive program," said
Dr. Michael Blue, a board certified urologist and Medical Director for MedCare Technologies. "I have even found male
patients that have become incontinent due to radical prostatectomy surgery benefiting from The MedCare Program. Since the
Program's inception in November, 1996, our office has been overwhelmed by the positive response from patients suffering
from incontinence."
The MedCare Program Does Not Require FDA Approval and is Risk Free
MedCare Technologies has developed a cost effective non-drug, non-surgical and non-invasive system for the care and
treatment of patients suffering from urinary incontinence. MedCare's treatment protocol does not require FDA approval, is
covered by most health insurance plans and results in the reduction or complete elimination of 70% to 100% of the most
commonly found urinary incontinence symptoms. Unlike traditional treatment options, which are costly, often unsuccessful or
inadequate, MedCare's treatment program is completely risk free and has a three year history with a proven success rate in
excess of 85%. MedCare Technologies offers a multi-modality program based on behavioral techniques and neuromuscular
electromyography biofeedback. The MedCare Program is designed to mobilize and strengthen various sensory- response
systems and is based on operant conditioning strategies whereby specific physiological responses are progressively shaped,
strengthened and coordinated.
Urinary Incontinence is a $16 Billion Market and Affects Almost Half of all Women
Numerous studies have been completed to determine the prevalence of urinary incontinence in the general population. The
results of one study completed at Emory University in Atlanta, GA. concluded that the prevalence of UI was 43.6% among
women and 20.9% among men. In another study of 3,638 patients over age 20, 1,908 women and 922 men completed an
anonymous questionnaire. A reported 43% of women and 11% of men had current UI. Almost 75% of these patients had not
informed a health professional, but more than a third of these said they would see a physician if treatment were available.
Affecting some 25 million Americans, UI is a $16 billion market and accounts for almost half of all nursing home admissions.
Despite being one of the most prevalent medical conditions in health care today, with almost half of all women being affected at
some point, UI remains a vastly under-serviced and over-looked market place. SOURCE MedCare Technologies Inc.
Help |
